We previously demonstrated that a subset of GBM is susceptible to arginine deprivation by ADI-PEG20 treatment due to methylation-dependent downregulation of ASS1 in vitro and in vivo using an orthotopic xenograft model of GBM (19, 20). Here, ASS1 is linked to glioblastoma.